Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/14685
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | openAccess | - |
dc.contributor.author | Đurđić Milošević, Tamara | - |
dc.date.accessioned | 2022-07-30T11:46:25Z | - |
dc.date.available | 2022-07-30T11:46:25Z | - |
dc.date.issued | 2019 | - |
dc.identifier.isbn | 9788676230884 | en_US |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/14685 | - |
dc.description | Rad je napisan u okviru projekta Pravnog fakulteta Univerziteta u Kragujevcu XXI vek – vek usluga i Uslužnog prava, br. 179012, koji finansira Ministarstvo prosvete, nauke i tehnološkog razvoja Republike Srbije. | en_US |
dc.description.abstract | The use of medicines implies a risk of damage to the patient. The danger of the use of a drug may be of a different nature, considering a chemical nature of the medical product, which also determines its pharmacological effect, thus disabling completely safe use of the drug. In fact, one should bear in mind the ambivalent effect of a drug which, besides therapeutic characteristic, has accompanying adverse effects on the health of the user, which is the risk one must count on. The institute of liability for damage (the responsible persons, the legal nature of the responsibility) is of particular importance for Serbian medical law, bearing in mind that it is not specifically regulated in the law. Further, this issue is complicated due to the fact that the implementation of the medical treatment involves a large number of persons: the doctor who prescribes the medicine, the drug manufacturer who issues the medicine, and the pharmacist who sells the drug. That is the reason why the liability for the damage using medicine, deserves special attention in the legal doctrine. | en_US |
dc.language.iso | sr | en_US |
dc.publisher | Faculty of Law, University of Kragujevac | en_US |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.source | XV Majsko savetovanje, Sloboda pružanja usluga i pravna sigurnost | en_US |
dc.subject | drug harm | en_US |
dc.subject | civil liability | en_US |
dc.subject | drug manufacturer | en_US |
dc.subject | doctor | en_US |
dc.subject | pharmacist | en_US |
dc.subject | drug user | en_US |
dc.title | ODGOVORNOST ZA ŠTETU OD LEKOVA | en_US |
dc.title.alternative | LIABILITY FOR DRUG DAMAGE | en_US |
dc.type | conferenceObject | en_US |
dc.description.version | Published | en_US |
dc.identifier.doi | 10.46793/XVMajsko.667DJ | en_US |
dc.type.version | PublishedVersion | en_US |
Appears in Collections: | Faculty of Law, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
15 majsko savetovanje 2019-667-678.pdf | 248.57 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License